Ontology type: schema:ScholarlyArticle
2010-05
AUTHORSYeo-Kyeoung Kim, Sang-Kyun Sohn, Jae-Hoon Lee, Deok-Hwan Yang, Joon-Ho Moon, Jae-Sook Ahn, Hyeoung-Joon Kim, Je-Jung Lee, The Korean Multiple Myeloma Working Party (KMMWP)
ABSTRACTThe clinical efficacy and safety of a four-drug combination of bortezomib, cyclophosphamide, thalidomide, and dexamethasone was assessed for patients with relapsed or refractory multiple myeloma. Seventy patients received at least two cycles of treatment with bortezomib 1.3 mg/m(2) intravenously on days 1, 4, 8, and 11; cyclophosphamide 150 mg/m(2) orally on days 1-4; thalidomide 50 mg/day orally every day; and dexamethasone 20 mg/m(2) intravenously on days 1, 4, 8, and 11. The overall best response rate was 88%, with 46% complete response, 9% very good partial response, and 33% partial response. After a median follow-up of 12.6 months, the median progression-free survival (PFS) was 14.6 months with a 3-year PFS of 14% and the median overall survival (OS) was 31.6 months with a 3-year OS of 47%. Grade 3 or 4 adverse events included thrombocytopenia (12%), neutropenia (4%), peripheral sensory neuropathy (3%), with thrombosis being very rare (<1%). Bortezomib combined with cyclophosphamide, thalidomide, and dexamethasone is a highly effective salvage therapy with manageable toxicity for patients with relapsed or refractory multiple myeloma. More... »
PAGES475-482
http://scigraph.springernature.com/pub.10.1007/s00277-009-0856-x
DOIhttp://dx.doi.org/10.1007/s00277-009-0856-x
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1031757447
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/19921192
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Boronic Acids",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Bortezomib",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclophosphamide",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dexamethasone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Multiple Myeloma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pyrazines",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Secondary Prevention",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Thalidomide",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Chonnam National University",
"id": "https://www.grid.ac/institutes/grid.14005.30",
"name": [
"Chonnam National University Medical School, Gwangju, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Kim",
"givenName": "Yeo-Kyeoung",
"id": "sg:person.01357201730.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357201730.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Kyungpook National University",
"id": "https://www.grid.ac/institutes/grid.258803.4",
"name": [
"Kyungpook National University Medical School, Daegu, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Sohn",
"givenName": "Sang-Kyun",
"id": "sg:person.0733030246.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733030246.01"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Gachon University",
"id": "https://www.grid.ac/institutes/grid.256155.0",
"name": [
"Gachon University, Incheon, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Lee",
"givenName": "Jae-Hoon",
"id": "sg:person.011413516720.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011413516720.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chonnam National University",
"id": "https://www.grid.ac/institutes/grid.14005.30",
"name": [
"Chonnam National University Medical School, Gwangju, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Yang",
"givenName": "Deok-Hwan",
"id": "sg:person.0753367262.83",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753367262.83"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Kyungpook National University",
"id": "https://www.grid.ac/institutes/grid.258803.4",
"name": [
"Kyungpook National University Medical School, Daegu, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Moon",
"givenName": "Joon-Ho",
"id": "sg:person.0631562615.89",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631562615.89"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chonnam National University",
"id": "https://www.grid.ac/institutes/grid.14005.30",
"name": [
"Chonnam National University Medical School, Gwangju, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Ahn",
"givenName": "Jae-Sook",
"id": "sg:person.01017560023.88",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017560023.88"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chonnam National University",
"id": "https://www.grid.ac/institutes/grid.14005.30",
"name": [
"Chonnam National University Medical School, Gwangju, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Kim",
"givenName": "Hyeoung-Joon",
"id": "sg:person.0617770714.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617770714.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chonnam National University Hwasun Hospital",
"id": "https://www.grid.ac/institutes/grid.411602.0",
"name": [
"Chonnam National University Medical School, Gwangju, Republic of Korea",
"The Brain Korea 21 Project, Center for Biomedical Human Resources at Chonnam National University, Gwangju, Republic of Korea",
"Department of Hematology\u2013Oncology, Chonnam National University Hwasun Hospital, 160, Ilsim-ri, Hwasun-eup, 519-809, Hwasun-gun, Jeollanam-do, Republic of Korea"
],
"type": "Organization"
},
"familyName": "Lee",
"givenName": "Je-Jung",
"id": "sg:person.01204441075.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204441075.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ministry of Education",
"id": "https://www.grid.ac/institutes/grid.452901.b",
"name": [
"The Brain Korea 21 Project, Center for Biomedical Human Resources at Chonnam National University, Gwangju, Republic of Korea"
],
"type": "Organization"
},
"familyName": "The Korean Multiple Myeloma Working Party (KMMWP)",
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1046/j.1365-2141.1999.01744.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001882433"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.1997.2783095.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004106004"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.1997.2783095.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004106004"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2005.05519.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004183784"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2005.05519.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004183784"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa070596",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006682290"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2004.05188.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007305374"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmra041875",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012036189"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1385/mo:19:4:219",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012981800",
"https://doi.org/10.1385/mo:19:4:219"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(04)15736-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022694967"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa030288",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028177288"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa070594",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029594313"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2007.14.9641",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030048132"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.1968.tb01542.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033176639"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/ajh.2830330203",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033518960"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2404284",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033553106",
"https://doi.org/10.1038/sj.leu.2404284"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2404284",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033553106",
"https://doi.org/10.1038/sj.leu.2404284"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2008.235",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037023799",
"https://doi.org/10.1038/leu.2008.235"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2007.14.2372",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037118108"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(89)91549-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040684628"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(89)91549-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040684628"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2005.04.7779",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042177697"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa0801479",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1043382081"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2006-08-042275",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046131633"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2008.07572.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046486104"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.leukres.2005.06.027",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051666591"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2006-08-036947",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053544069"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1023/a:1011132808904",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1056304933"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.thj.6200150",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1056649418",
"https://doi.org/10.1038/sj.thj.6200150"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1074805906",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.6004/jnccn.2007.0015",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1077379991"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.6004/jnccn.2007.0015",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1077379991"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083365908",
"type": "CreativeWork"
}
],
"datePublished": "2010-05",
"datePublishedReg": "2010-05-01",
"description": "The clinical efficacy and safety of a four-drug combination of bortezomib, cyclophosphamide, thalidomide, and dexamethasone was assessed for patients with relapsed or refractory multiple myeloma. Seventy patients received at least two cycles of treatment with bortezomib 1.3 mg/m(2) intravenously on days 1, 4, 8, and 11; cyclophosphamide 150 mg/m(2) orally on days 1-4; thalidomide 50 mg/day orally every day; and dexamethasone 20 mg/m(2) intravenously on days 1, 4, 8, and 11. The overall best response rate was 88%, with 46% complete response, 9% very good partial response, and 33% partial response. After a median follow-up of 12.6 months, the median progression-free survival (PFS) was 14.6 months with a 3-year PFS of 14% and the median overall survival (OS) was 31.6 months with a 3-year OS of 47%. Grade 3 or 4 adverse events included thrombocytopenia (12%), neutropenia (4%), peripheral sensory neuropathy (3%), with thrombosis being very rare (<1%). Bortezomib combined with cyclophosphamide, thalidomide, and dexamethasone is a highly effective salvage therapy with manageable toxicity for patients with relapsed or refractory multiple myeloma.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00277-009-0856-x",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1018247",
"issn": [
"1269-3286",
"1279-8509"
],
"name": "Annals of Hematology",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "89"
}
],
"name": "Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study",
"pagination": "475-482",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"97492ed20d6b9d293bf68473f2831fc074bc8de35380f10a70b0ce5c023109d8"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"19921192"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9107334"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00277-009-0856-x"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1031757447"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00277-009-0856-x",
"https://app.dimensions.ai/details/publication/pub.1031757447"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T14:28",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13081_00000001.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007/s00277-009-0856-x"
}
]Download the RDF metadata as:Â json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-009-0856-x'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-009-0856-x'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-009-0856-x'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-009-0856-x'
This table displays all metadata directly associated to this object as RDF triples.
295 TRIPLES
21 PREDICATES
75 URIs
39 LITERALS
27 BLANK NODES